MCC
BIB icon

Money Concepts Capital’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Money Concepts Capital’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,000
Closed -$202K – 1550
2022
Q2 		$202K Hold
4,000
– – 0.02% 413
2022
Q1 		$248K Hold
4,000
– – 0.01% 645
2021
Q4 		$324K Buy
+4,000
New +$343K 0.03% 386
2021
Q1 		– Sell
-100
Closed -$9K – 717
2020
Q4 		$9K Buy
+100
New +$7.74K ﹤0.01% 607

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CG
Cutler Group San Francisco, California $307M AUM 45.11% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Money Concepts Capital's BIB Position: Q3 2022 in Review

Money Concepts Capital sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2022, closing a stake of 4,000 shares — an estimated $202K sold.

Money Concepts Capital first reported a position in BIB in Q4 2020 and held it in 4 quarters. The position peaked at $324K in Q4 2021. 19 funds tracked by Wall St. Rank hold BIB as of Q3 2022.

  • Money Concepts Capital reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2022 after selling out during the quarter.
  • Money Concepts Capital sold 4,000 ProShares Ultra NASDAQ Biotechnology shares in Q3 2022, an estimated $202K.
  • Money Concepts Capital first reported a position in ProShares Ultra NASDAQ Biotechnology in Q4 2020 and held it in 4 quarters.
  • Money Concepts Capital's ProShares Ultra NASDAQ Biotechnology position peaked at $324K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2022.

Based on Money Concepts Capital's 13F filing for Q3 2022, filed 27 Oct 2022.